| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3390/IJMS20174241 |
| P953 | full work available at URL | https://www.mdpi.com/1422-0067/20/17/4241 |
| P932 | PMC publication ID | 6747121 |
| P698 | PubMed publication ID | 31480219 |
| P50 | author | Jean S Marshall | Q60329463 |
| P2093 | author name string | Liliana Portales-Cervantes | |
| Jean S. Marshall | |||
| Edwin Leong | |||
| P2860 | cites work | Interferon α2 and interferon γ induce the degranulation independent production of VEGF-A and IL-1 receptor antagonist and other mediators from human mast cells | Q47299162 |
| Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 Production | Q48263999 | ||
| Submucosal mast cells in the gastrointestinal tract are a target of staphylococcal enterotoxin type A. | Q50261433 | ||
| Recognition of single-stranded RNA viruses by Toll-like receptor 7 | Q24568101 | ||
| Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection | Q24633526 | ||
| Dengue virus selectively induces human mast cell chemokine production | Q24673736 | ||
| Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line | Q27469685 | ||
| Staphylococcus aureus infections | Q28131787 | ||
| Dectin-1 mediates the biological effects of beta-glucans | Q28509437 | ||
| Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48 | Q28574579 | ||
| Toll-like receptor 4-mediated activation of murine mast cells | Q28585932 | ||
| Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice | Q28744391 | ||
| Intranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5. | Q30356284 | ||
| Porcine mast cells infected with H1N1 influenza virus release histamine and inflammatory cytokines and chemokines | Q30396997 | ||
| Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. | Q51747715 | ||
| Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. | Q54577327 | ||
| Role of Host Cell Secretory Machinery in Zika Virus Life Cycle | Q57466493 | ||
| The monocyte-macrophage-mast cell axis in dengue pathogenesis | Q58582556 | ||
| Cryptococcus neoformans Cda1 and Its Chitin Deacetylase Activity Are Required for Fungal Pathogenesis | Q59793148 | ||
| Mast Cells Respond to Candida albicans Infections and Modulate Macrophages Phagocytosis of the Fungus | Q59798724 | ||
| Mast Cells as Sensors of Cell Injury through IL-33 Recognition | Q63257866 | ||
| Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin | Q63370231 | ||
| Superantigenic Activation of Human Cardiac Mast Cells | Q64251899 | ||
| Is histamine responsible for the symptoms of rhinovirus colds? a look at the inflammatory mediators following infection | Q68316299 | ||
| The effect of parainfluenza 3 infection on guinea pig basophil and lung mast cell histamine release | Q69056648 | ||
| Cholera toxin increases IL-6 synthesis and decreases TNF-alpha production by rat peritoneal mast cells | Q70994110 | ||
| Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice | Q74477573 | ||
| MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo | Q81447079 | ||
| Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells | Q84328029 | ||
| Dengue virus-elicited tryptase induces endothelial permeability and shock | Q91552439 | ||
| Staphylococcal superantigen-like 12 activates murine bone marrow derived mast cells | Q91841193 | ||
| Altered mast cell activity in response to rhinovirus infection provides novel insight into asthma | Q92435052 | ||
| Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. | Q33381253 | ||
| Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations | Q33578155 | ||
| Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. | Q33591087 | ||
| Human Mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro | Q33848931 | ||
| Chitin synthesis and fungal pathogenesis. | Q34073565 | ||
| Association of mast cell-derived VEGF and proteases in Dengue shock syndrome | Q34171756 | ||
| RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. | Q34222029 | ||
| Extracts of mosquito salivary gland inhibit tumour necrosis factor alpha release from mast cells | Q34305754 | ||
| Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells. | Q34352267 | ||
| Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites | Q34503403 | ||
| Chitin and Its Effects on Inflammatory and Immune Responses. | Q34552477 | ||
| Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance | Q35021816 | ||
| Influence of mast cells on dengue protective immunity and immune pathology | Q35075102 | ||
| Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors | Q35183803 | ||
| Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses | Q35186951 | ||
| Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides | Q35629472 | ||
| Granulocytes in Ocular HSV-1 Infection: Opposing Roles of Mast Cells and Neutrophils | Q35746727 | ||
| Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells | Q35768621 | ||
| Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status | Q35795457 | ||
| Mast cell-induced lung injury in mice infected with H5N1 influenza virus | Q35826260 | ||
| Human tissue mast cells are an inducible reservoir of persistent HIV infection | Q35839856 | ||
| Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses | Q36139858 | ||
| Influenza Infection in Mice Induces Accumulation of Lung Mast Cells through the Recruitment and Maturation of Mast Cell Progenitors | Q36337434 | ||
| The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. | Q36416493 | ||
| Human Mucosal Mast Cells Capture HIV-1 and Mediate Viral trans-Infection of CD4+ T Cells | Q36736648 | ||
| Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling | Q36788220 | ||
| Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage | Q36804428 | ||
| The role of the beta-glucan receptor Dectin-1 in control of fungal infection | Q36809539 | ||
| Infection of immune mast cells by Harvey sarcoma virus: immortalization without loss of requirement for interleukin-3 | Q36892809 | ||
| Effects of staphylococcal enterotoxin B on rodent mast cells | Q36948117 | ||
| The Vibrio cholerae cytolysin promotes activation of mast cell (T helper 2) cytokine production | Q36989717 | ||
| Failure to detect active virus replication in mast cells at various tissue sites of HIV patients by immunohistochemistry | Q37376685 | ||
| TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells | Q38339799 | ||
| Limited replication of influenza A virus in human mast cells | Q38457553 | ||
| Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4. | Q38893615 | ||
| Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. | Q39177814 | ||
| HIV-1 Nef promotes migration and chemokine synthesis of human basophils and mast cells through the interaction with CXCR4. | Q39206825 | ||
| Virus-Infected Human Mast Cells Enhance Natural Killer Cell Functions. | Q39223498 | ||
| Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model | Q39270949 | ||
| IL-16 regulation of human mast cells/basophils and their susceptibility to HIV-1. | Q39373071 | ||
| Histamine release from rat mast cells induced by Sendai virus | Q39468697 | ||
| Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells | Q39499091 | ||
| Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity | Q39737899 | ||
| Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus | Q39887208 | ||
| Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation | Q40067512 | ||
| A Role for Human Skin Mast Cells in Dengue Virus Infection and Systemic Spread | Q40082082 | ||
| HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs | Q40092894 | ||
| Mast cell-macrophage dynamics in modulation of dengue virus infection in skin | Q40152339 | ||
| Dengue virus infection of mast cells triggers endothelial cell activation. | Q40343791 | ||
| A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. | Q40471250 | ||
| Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils | Q40716487 | ||
| Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages | Q40737206 | ||
| CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells | Q40818191 | ||
| Mast cells phagocyte Candida albicans and produce nitric oxide by mechanisms involving TLR2 and Dectin-1. | Q40973852 | ||
| Recognition of Candida albicans by Dectin-1 induces mast cell activation. | Q41206794 | ||
| IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. | Q41661699 | ||
| Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. | Q41665309 | ||
| Chymase is a Predictive Biomarker of Dengue Hemorrhagic Fever in Pediatric and Adult Patients | Q41928393 | ||
| Rat mast cells permeabilized with Sendai virus secrete histamine in response to Ca2+ buffered in the micromolar range | Q42076544 | ||
| TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. | Q42132922 | ||
| Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation | Q42957126 | ||
| Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis. | Q43039469 | ||
| Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells | Q43809556 | ||
| Infection of in vivo differentiated human mast cells with hantaviruses | Q43945372 | ||
| Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. | Q44164203 | ||
| Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome | Q44233780 | ||
| Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. | Q44306884 | ||
| Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells | Q44715236 | ||
| Mast cell activation and leukotriene secretion in wheezing infants. Relation to respiratory syncytial virus and outcome | Q44783797 | ||
| HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. | Q44787579 | ||
| Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice | Q45201335 | ||
| Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production | Q45352000 | ||
| Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands. | Q45361401 | ||
| Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. | Q45395701 | ||
| Parainfluenza virus-induced persistence of airway inflammation, fibrosis, and dysfunction associated with TGF-beta 1 expression in brown Norway rats | Q45765726 | ||
| The role of mast cells in virus-induced inflammation in the murine central nervous system | Q45796403 | ||
| Production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines | Q45831299 | ||
| Pathogenesis of naturally acquired bovine respiratory syncytial virus infection in calves: evidence for the involvement of complement and mast cell mediators | Q45843004 | ||
| Parainfluenza-3 virus-induced enhancement of histamine release from calf lung mast cells--effect of levamisole | Q45847441 | ||
| Immortalization of murine connective tissue-type mast cells at multiple stages of their differentiation by coculture of splenocytes with fibroblasts that produce Kirsten sarcoma virus | Q45847568 | ||
| Brown Norway rats are high responders to bronchiolitis, pneumonia, and bronchiolar mastocytosis induced by parainfluenza virus | Q45861118 | ||
| Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. | Q45968849 | ||
| The Role of Mast Cells in Tuberculosis: Orchestrating Innate Immune Crosstalk? | Q47130424 | ||
| Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. | Q47229699 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mast cell | Q191989 |
| P304 | page(s) | 4241 | |
| P577 | publication date | 2019-01-01 | |
| 2019-08-30 | |||
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Mast Cell Responses to Viruses and Pathogen Products | |
| P478 | volume | 20 |
| Q92661015 | Mast Cells: Fascinating but Still Elusive after 140 Years from Their Discovery |
| Q110245835 | SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury |
| Q95630634 | Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19 |
| Q90461487 | The Absence of Tryptase Mcpt6 Causes Elevated Cellular Stress in Response to Modulation of the Histone Acetylation Status in Mast Cells |
| Q90414952 | The Response of Tissue Mast Cells to TLR3 Ligand Poly(I:C) Treatment |
| Q107102118 | The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication |
Search more.